FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells

Ju,Yinghua; Xu,Taojun; Zhang,Hongkai; Yu,Aiming

doi:10.3892/ijo.2014.2269

FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells

Authors:
- Yinghua Ju
- Taojun Xu
- Hongkai Zhang
- Aiming Yu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, China Medical University, Shenyang 110001, P.R. China
Published online on: January 21, 2014 https://doi.org/10.3892/ijo.2014.2269
Pages: 1284-1292

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

DNA damage or mutation in cells contributes to tumorigenesis. The transcription factor FOXO1 modulates the expression of genes involved in DNA damage repair, cell cycle arrest and apoptosis. The transcriptional activity of FOXO1 is fundamentally regulated by post-translational modification and subcellular localization. H1299 lung cancer cells were treated with the alkylating agent MNNG, and the cell viability and DNA damage were separately determined by MTT and comet assay. Using immunofluorescence and western blotting, we observed the subcellular localization of FOXO1 and measured the relevant protein expression levels, respectively. To examine cell cycle arrest and apoptosis, flow cytometry analysis was preformed. The interaction between FOXO1 and JNK was analyzed through immunoprecipitation. Our results showed that cell viability was reduced at 24 h after MNNG treatment, and appeared to recover to some degree at 48 h. The increased expression and nuclear export of FOXO1 emerged at 4 h after the treatment. Nuclear FOXO1 played a pivotal role in cell cycle arrest, apoptosis and DNA damage repair by upregulating p27Kip1, Bim and GADD45 gene expression, respectively. AKT-dependent S256 phosphorylation of FOXO1 and the S473 phosphorylation of AKT were both enhanced following DNA damage. Moreover, our studies revealed that FOXO1 directly interacted with JNK, and the inhibition of the JNK activity led to decreased expression of FOXO1 target genes. These findings suggest for the first time that FOXO1 is a promising candidate substrate for JNK, and the FOXO1-dependent DNA damage repair may be regulated positively by the JNK pathway in H1299 lung cancer cells.

View Figures

View References

1.	Hoeijmakers JH: DNA damage, aging, and cancer. N Engl J Med. 361:1475–1485. 2009. View Article : Google Scholar
2.	Sedgwick B, Bates PA, Paik J, Jacobs SC and Lindahl T: Repair of alkylated DNA: recent advances. DNA Repair. 6:429–442. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Maher RL, Branagan AM and Morrical SW: Coordination of DNA replication and recombination activities in the maintenance of genome stability. J Cell Biochem. 112:2672–2682. 2011. View Article : Google Scholar : PubMed/NCBI
4.	Fu D, Calvo JA and Samson LD: Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 12:104–120. 2012.
5.	Zhou BB and Elledge SJ: The DNA damage response: putting checkpoints in perspective. Nature. 408:433–439. 2012.PubMed/NCBI
6.	Lam M, Carmichael AR and Griffiths HR: An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression. PLoS One. 7:e401522012.PubMed/NCBI
7.	Greer EL and Brunet A: FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Maiese K, Chong ZZ, Shang YC and Hou J: Clever cancer strategies with FoxO transcription factors. Cell Cycle. 7:3829–3839. 2008. View Article : Google Scholar : PubMed/NCBI
9.	Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS, Chiang LW and Greenberg ME: DNA repair pathway stimulated by the Forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 296:530–534. 2002. View Article : Google Scholar : PubMed/NCBI
10.	Lei H and Quelle FW: FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage. Mol Cancer Res. 7:1294–1303. 2009. View Article : Google Scholar : PubMed/NCBI
11.	de Keizer PL, Packer LM, Szypowska AA, Riedl-Polderman PE, van den Broek NJ, de Bruin A, Dansen TB, Marais R, Brenkman AB and Burgering BM: Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. Cancer Res. 70:8526–8536. 2010.PubMed/NCBI
12.	Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Yang JY and Hung MC: A new fork for clinical application: targeting forkhead transcription factors in cancer. Clin Cancer Res. 15:752–757. 2009. View Article : Google Scholar : PubMed/NCBI
14.	Vogt PK, Jiang H and Aoki M: Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle. 4:908–913. 2005. View Article : Google Scholar : PubMed/NCBI
15.	Rena G, Prescott AR, Guo S, Cohen P and Unterman TG: Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targeting. Biochem J. 354:605–612. 2001. View Article : Google Scholar : PubMed/NCBI
16.	Essers MA, Weijzen S, Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL and Burgering BM: FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23:4802–4812. 2004. View Article : Google Scholar
17.	Fu Z and Tindall DJ: FOXOs, cancer and regulation of apoptosis. Oncogene. 27:2312–2319. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC and Sasaki YF: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 35:206–221. 2000. View Article : Google Scholar
19.	Dhawan A, Bajpayee M and Parmar D: Comet assay: a reliable tool for the assessment of DNA damage in different models. Cell Biol Toxicol. 25:5–32. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug G and Krokan HE: Alkylation damage in DNA and RNA - repair mechanisms and medical significance. DNA Repair. 3:1389–1407. 2004.PubMed/NCBI
21.	Cok I, Ulutaş OK, Okuşluk O, Durmaz E and Demir N: Evaluation of DNA damage in common carp (Cyprinus carpio L.) by comet assay for determination of possible pollution in Lake Mogan (Ankara). Sci World J. 11:1455–1461. 2011.PubMed/NCBI
22.	Schroering AG and Williams KJ: Rapid induction of chromatin-associated DNA mismatch repair proteins after MNNG treatment. DNA Repair. 7:951–969. 2008. View Article : Google Scholar : PubMed/NCBI
23.	Jasin M: Homologous repair of DNA damage and tumori genesis: the BRCA connection. Oncogene. 21:8981–8993. 2002. View Article : Google Scholar : PubMed/NCBI
24.	Abraham RT: Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2177–2196. 2001. View Article : Google Scholar : PubMed/NCBI
25.	Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP and Elledge SJ: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 316:1160–1166. 2007. View Article : Google Scholar
26.	Hirano M, Hirano K, Nishimura J and Kanaide H: Transcriptional up-regulation of p27 (Kip1) during contact-induced growth arrest in vascular endothelial cells. Exp Cell Res. 271:356–367. 2001. View Article : Google Scholar : PubMed/NCBI
27.	Hildesheim J and Fornace AJ Jr: Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer. Clin Cancer Res. 8:2475–2479. 2002.PubMed/NCBI
28.	Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM and Medema RH: The forkhead transcription factor FoxO regulates transcription of p27^Kip1 and Bim in response to IL-2. J Immunol. 168:5024–5031. 2002. View Article : Google Scholar : PubMed/NCBI
29.	Nakamura T and Sakamoto K: Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. Mol Cell Endocrinol. 281:47–55. 2008. View Article : Google Scholar : PubMed/NCBI
30.	Maiese K, Chong ZZ, Hou J and Shang YC: The ‘O’ class: crafting clinical care with FoxO transcription factors. Adv Exp Med Biol. 665:242–260. 2009.
31.	Matsuzaki H, Daitoku H, Hatta M, Tanaka K and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA. 100:11285–11290. 2003. View Article : Google Scholar
32.	Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
33.	Lüpertz R, Chovolou Y, Unfried K, Kampkötter A, Wätjen W and Kahl R: The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity. Carcinogenesis. 29:2045–2052. 2008.PubMed/NCBI
34.	Wang MC, Bohmann D and Jasper H: JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell. 121:115–125. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Hong YK, Lee S, Park SH, Lee JH, Han SY, Kim ST, Kim YK, Jeon S, Koo BS and Cho KS: Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer’s disease model. Biochem Biophys Res Commun. 419:49–53. 2012.PubMed/NCBI